Stem Cells USA is where experts like Argos Therapeutic's Fred Miesowicz gather to network, learn from each other, and discuss the latest stem cell strategies and technology.

Fred Miesowicz of Argos Therapeutics on Automated Manufacturing and Commercial Planning

Fred Miesowicz, Chief Operating Officer of Argos Therapeutics, presented at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides from the event, where he addresses how to benefit from automated manufacturing and commercial planning from very early stages of development. You can also view the recording of his presentation alongside these slides, so …

Increasing struggles in cell therapies manufacturing as production ramps up

Even though there has been an increasing number of cell therapies advancing to late-stage clinical development, several aspects of cell therapy development continue to present considerable challenges for large scale commercialization. It is clear that production of biologics in general carries higher risks than of small molecules pharmaceuticals and this becomes even more evident as production of cell therapies ramps …